‘Wait for the Year-End Rally,’ Says Morgan Stanley; Here Are 2 Stocks to Play That Bullish Outlook

S&P Futures

3,876.50

-25.50(-0.65%)

 

Dow Futures

30,794.00

-180.00(-0.58%)

 

Nasdaq Futures

11,837.25

-97.50(-0.82%)

 

Russell 2000 Futures

1,821.30

-10.00(-0.55%)

 

Crude Oil

85.28

+0.18(+0.21%)

 

Gold

1,671.50

-5.80(-0.35%)

 

Silver

19.15

-0.12(-0.64%)

 

EUR/USD

0.9995

-0.0005(-0.05%)

 

10-Yr Bond

3.4590

+0.0470(+1.38%)

 

Vix

26.27

+0.11(+0.42%)

 

GBP/USD

1.1456

-0.0011(-0.10%)

 

USD/JPY

143.4830

+0.0260(+0.02%)

 

BTC-USD

19,718.00

-361.69(-1.80%)

 

CMC Crypto 200

460.51

-16.88(-3.54%)

 

FTSE 100

7,282.07

+4.77(+0.07%)

 

Nikkei 225

27,574.58

-301.33(-1.08%)

 

After three months of highly volatile trading, which have seen the S&P 500 drop down toward 3,600, rally up to 4,300, and fall back down to 3,900, investors can be forgiven for feeling some whiplash. The question that needs answering, however, is where will the markets go from here?

Morgan Stanley strategist Andrew Slimmon believes that investors shouldn’t worry too much about the bear case. Worse-than-expected inflation numbers for August may have pushed the markets into a tumble this week, but in Slimmon’s view, the S&P should show a recovery by year’s end, and finish up close to where it started, near 4,700. That would represent an increase of 17% from current levels.

“Positioning is uniformly bearish. And I suspect that will flip at some point in Q4 pushing the [S&P 500] higher into year-end, not lower,” Slimmon noted.

Slimmon bases his conviction on evidence that inflation is starting to slip back down, after peaking in July. “It’s not coming down very fast, but it is coming down,” Slimmon said.

With this in mind, we wanted to take a closer look at two stocks that received Morgan Stanley’s stamp of approval, with the firm projecting upside potential of more than 30% for each. Using TipRanks’ database, we found out that the rest of the Street is also on board as both have earned a “Strong Buy” consensus rating.

Alphatec Holdings (ATEC)

We’ll start with medical technology. Alphatec Holdings owns three subsidiary companies which, between them, are bringing dramatic changes to field of spinal surgery. The company markets a series of medical devices that bring a new approach to spine surgery, from the neck down to the pelvic vertebrae. The company’s goal is to create a surgical approach with a clinical distinction, one that will make Alphatec the ‘Standard Bearer in Spine.’

New surgical methods can open up expanding vistas for a well-positioned med-tech company, and Alphatec’s recent financial results support that. In the second quarter of this year, Alphatec saw a top line of $84 million. That was up 35% from the year-ago quarter.

On earnings, Alphatec has been running consistent losses, which deepened from 2020 to 2021. The 2Q22 net loss of $36 million, however, represented a moderation from recent quarters. And, the company reported a cash holding of $107 million against operating expenses of $91 million.

Looking forward, Alphatec is expecting full-year revenue of $325 million for 2022. That figure would represent 34% year-over-year growth.

Strong growth would appear to be the story here, as Morgan Stanley analyst Drew Ranieri points out.

“Over the past 10 quarters, the company has averaged nearly 40% quarterly organic revenue growth, vs. the 9% median for pure-play spine peers. Unlike larger competitors, Alphatec’s commercial growth is not tethered to market growth in our view. With roughly 2.5% share today, Alphatec has significant runway ahead to drive sustainable double-digit revenue growth. We assume Alphatec doubles its market share to nearly 6% by ’26, with total company revenue reaching $673mn implying an approximate 20% CAGR over 2022-2026e,” Ranieri opined.

“Alphatec shares and peers has narrowed significantly as the turnaround narrative has been de-risked and investors have better appreciated the multi-faceted growth story; however, Alphatec shares currently look underappreciated vs. peers in our view,” the analyst summed up.

To this end, Ranieri sets an Overweight (i.e. Buy) rating on ATEC shares, along with a $13 price target that shows potential for a 47% upside in the year ahead. (To watch Ranieri’s track record, click here)

Overall, it’s safe to say that the Street agrees with this bullish view of Alphatec. The stock has 5 recent analyst reviews, which break down to 4 Buys and 1 Hold for a Strong Buy consensus rating. The average price target on ATEC shares, $12.90, is practically the same as Ranieri’s. (See ATEC stock forecast on TipRanks)

Bill.com Holdings (BILL)

Let’s stick with tech, but move over to fintech. Bill.com Holdings is a software provider, offering cloud-based solutions for small businesses to deal with accounting and paperwork issues. The company’s software lets users simplify, digitize, and automate back-office financial processes, for great overall efficiency of day-to-day operations. BILL’s products can be used for billing, invoicing, making and receiving payments, and other time-consuming bookkeeping tasks.

The company’s target customers are small- and mid-sized businesses, and BILL is popular among small entrepreneurs. The company finished its fiscal year 2022 on June 30, and a look at its Q4 and full year results shows the extent of its popularity and growth. The fiscal fourth quarter saw the company boast some 400,000 business customers, and surpass $200 million in quarterly revenues. Year-over-year, the top line was up an impressive 156%, from $78.3 million in the year-ago period.

Like many tech and/or software firms, BILL tends to run a net loss – but the net loss in fiscal Q4 came in at just $3.3 million, compared to $5.8 million on year earlier. On an EPS basis, the loss was 3 cents per diluted share, less than half the 7 cents reported in fiscal 4Q21.

Even though BILL’s revenues are rising sharply, the stock has underperformed this year. Shares in BILL are down 36% year-to-date, compared to the 18% year-to-date loss on the S&P 500.

The falling stock price strikes Morgan Stanley’s Keith Weiss, a 5-star analyst, as an opportunity. He initiated his coverage of BILL with some laudatory comments, writing: “A compelling value proposition, differentiated go-to-market strategy through direct sales, accounting partnerships, and financial institution partners, supporting a +65% revenue CAGR (CY21–CY23E), the second fastest in our coverage, and a solid track record of execution create a favorable risk/reward for BILL.”

Weiss puts an Overweight (i.e. Buy) rating here, and sets the price target at $220, implying a one-year gain potential of ~38%. (To watch Weiss’s track record, click here)

Tech and software typically get more than their share of Wall Street interest, and BILL is no exception. The stock has 21 recent analyst reviews on file, and these include 19 Buys against just 2 Holds, for a Strong Buy consensus view. The shares are selling for $158.84 and the $208.35 average price target suggests an upside of 31% for the year ahead. (See BILL stock forecast on TipRanks)

To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Advertisement

TipRanks

Warren Buffet Is Using These Dividend Stocks to Fight Inflation and Generate Passive Income Stream

Markets tanked yesterday, there’s no other way to put it. The NASDAQ fell more than 5%, the S&P 500 fell more than 4%, and the Dow Jones shed 1,200 points, also a 4% loss. The sharp drops hit after the official August inflation numbers came in substantially worse than expectations. The data release has also firmed up convictions that the Federal Reserve will enact another 75 basis point rate hike later this month. Taken together, rising prices and higher interest rates increase the chances of a

Benzinga

Lock In High Dividend Yields While Prices Are Down On These 3 REITs

If history is any indication, one of the best ways to make long-term money in the stock market is by having the courage to buy stocks when they are largely out of favor. This is especially true of dividend stocks because when the prices decline, investors can lock in higher dividend yields for life. Certainly, investors should do their homework to ascertain the safety and reliability of a company’s dividends before buying on the basis of yield alone. Here are three real estate investment trusts

TheStreet.com

Pay Attention to the Bond Market for an ‘All-Sell’ Signal

There is always a collective groan in the classroom when the teacher turns the lesson to a subject that no student likes. In that vein, sorry, but I need to talk about the bond market today. It has been absolutely awful this year.

Benzinga

3 REITs For Reliable Passive Income

You’re an investor who’s looking at retirement in just a few short years. You want to transition from growth investments to income-producing instruments. You want solid investments you can hang on to for several years, but you’re looking for a higher yield than what’s available with bank certificates of deposit or U.S. Treasuries. There are certainly good stocks trading on the exchanges that pay decent dividends, but you’re looking for the stability of real estate. If this sounds like you, here

SmartAsset

How to Buy More than $10,000 in I Bonds Through This Loophole

In a world where the stock market is unpredictable and interest rates are rising, many investors are looking for someplace to put their money that is as close to risk-free as possible – even if it means forgoing the chance … Continue reading → The post How to Buy More than $10,000 in I Bonds Through This Loophole appeared first on SmartAsset Blog.

MarketWatch

These 20 stocks have short interest of 19% or more, and AMC and GameStop are not even in the top half

DEEP DIVE Short selling is a trading technique that gets especially popular during bear markets in stocks. Short selling — or betting on a decline in prices — can come to the fore if investors suspect a company is entering a difficult period, during a period of stress on financial markets, or when a group of traders acts to bid up the shares of companies that professional investors have bet against.

Reuters

S&P 500 futures drop after FedEx stokes fears about economy

S&P 500 futures fell on Thursday, suggesting traders expect Wall Street to open down in its next session, after FedEx withdrew its financial forecast and added to worries about a slowing global economy. After trading resumed following a daily maintenance period, S&P 500 e-mini futures fell 0.6%. Nasdaq futures dropped 0.7%.

Barrons.com

Cash Is No Longer Trash. T-Bill Yields Near 4%.

Surging yields don’t just benefit seniors and savers. They help companies like Berkshire Hathaway, Apple, Alphabet, and Microsoft sitting on tens of billions in cash.

Insider Monkey

10 Blue Chip Dividend Stocks to Buy After the Market Selloff

In this article, we discuss 10 blue chip dividend stocks to buy after the market selloff. You can skip our detailed analysis of a recent selloff and its future implications, and go directly to read 5 Blue Chip Dividend Stocks to Buy After the Market Selloff. The decline of the US stock market this year […]

Bloomberg

Asian Stocks Head for Fifth Straight Weekly Drop: Markets Wrap

(Bloomberg) — Asian stocks headed for a fifth week of declines following more weakness in US equities and a surge in short-end Treasury yields that reflects expectations for outsized Federal Reserve interest rate hikes.Most Read from BloombergAdobe Near Deal for Online Design Startup Figma, Sources SayRay Dalio Does the Math: Rates at 4.5% Would Sink Stocks by 20%Putin Acknowledges Xi’s ‘Concerns’ on Ukraine, Showing TensionPutin’s Options Narrow After Ukraine Scores Battlefield RoutAdobe Tumbl

Bloomberg

Figma’s Record-Breaking Sale to Adobe Delivers Billions to Top VCs

(Bloomberg) — Danny Rimer first invested in Figma in 2012, shortly after the company was established and began developing software tools for designers. Rimer, a partner at the venture capital firm Index Ventures, invited Figma’s co-founder and chief executive officer, Dylan Field, to dinner and ordered a bottle of wine to celebrate the deal. It was then that the young entrepreneur hesitated. “Danny, I’m 19,” Field said. Rimer went ahead, he recalled, and ordered the Pinot anyway.On Thursday, Ad

Leave A Reply

Your email address will not be published.